KYMERA
Live / Registered — Registered (as of 05 Nov 2024)
What this means for you
Registered since 05 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981116
- Registration number
- 7559572
- Mark type
- Design + words
- Filed
- 16 Nov 2020
- Published for opposition
- 31 Aug 2021
- Registered
- 05 Nov 2024
- Attorney of record
- Lisa M. Tittemore
Goods and services
- Class 042 — Scientific and technological services: Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of pharmaceuticals, and research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products
Owner
- Kymera Therapeutics, Inc., Watertown, MA, US
- Kymera Therapeutics, Inc., Watertown, MA, US
- Kymera Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 13 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Sept 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 12 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Apr 2024 — USE AMENDMENT FILED
- 17 Jul 2024 — DIVISIONAL PROCESSING COMPLETE
- 26 Apr 2024 — DIVISIONAL REQUEST RECEIVED